Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Benefits topic
No spam. Unsubscribe anytime.
City health plan projected to finish 2026 with $800,000 deficit; consultants recommend network and plan changes
Summary
IMA consultants told the Pittsburg commission the self‑funded city health plan is running a projected $800,000 deficit for 2026 and urged changes including a network rebid, stricter stop‑loss wording, and modest employee contribution increases to stabilize reserves.
IMA consultants presented an analysis showing the city’s self‑funded health plan has outperformed market trends historically but is now running a significant shortfall driven by high medical and pharmacy claims.
Nick Johnston, client executive for IMA, told commissioners the plan could finish 2026 “at about an $800,000 deficit.” He and Christy Powell walked the commission through claims detail from 2012–2025 and singled out a rare, multi‑year catastrophic inpatient claim and a pharmacy spike tied to GLP‑1 weight‑loss drugs as major drivers of recent cost increases.
The consultants showed that medical claims jumped from about $984,000 in 2023 to roughly $1.8 million in 2024, with pharmacy claims rising from about $600,000 to $813,000 between 2024 and 2025. Johnston noted that a single line‑item for weight‑loss prescriptions accounted for roughly $284,000 of pharmacy spend: “that was $284,000,” he said, when describing claims for Wegovy used for weight loss as opposed to diabetes treatment.
IMA recommended several options to bring the plan back toward balance. Those included: switching the plan’s medical network to PHCS, a change the consultants estimate could yield roughly $370,000 in network savings; pursuing a “gapless” stop‑loss contract to avoid run‑out exposures; targeted plan‑design adjustments (higher deductibles or copays for selected services) estimated to save roughly $210,000 annually; and modest employee contribution increases (examples shown: +$25–$35 per month by coverage tier).
On GLP‑1 prescriptions, Johnston said plan rules would be tightened going forward so members could fill those drugs only for diabetes—with prior authorization—rather than for weight management. He summarized the operational tradeoffs the commission faces: “we’re trying to balance fixed costs with the exposure of this particular claim,” and cautioned that a stronger stop‑loss or richer run‑out coverage would increase fixed costs.
Commissioners pressed for more employee communications and benchmarking material they can share during open enrollment; staff and IMA agreed to prepare an employee‑facing video and open‑enrollment materials. The presentation closed with no formal vote; staff said the recommendations will be folded into the budget process and return to the commission for action if the city chooses to adopt plan or contract changes.
